"The board confirms its commitment to continuing the strategy and the international expansion of the group based on research and innovation and its growth platforms," Sanofi's board said in a statement.

Sanofi shares fell 4 percent after the announcement.

(Reporting by Natalie Huet; Editing by James Regan)